14.60
Transcode Therapeutics Inc Aktie (RNAZ) Neueste Nachrichten
Does TransCode Therapeutics Inc. fit your quant trading modelJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
CK Life Merges Polynoma with TransCode in $125M DealNews and Statistics - IndexBox
CK Life Sciences sees low geopolitical risks in a US merger - The Standard (HK)
Multi asset correlation models including TransCode Therapeutics Inc.July 2025 Highlights & Risk Managed Investment Strategies - newser.com
TransCode Therapeutics (NASDAQ:RNAZ) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World
Critical Analysis: Century Therapeutics (NASDAQ:IPSC) and TransCode Therapeutics (NASDAQ:RNAZ) - Defense World
CKLIFE SCIENCES Estimates Completion of TransCode Preferred Stock Conversion in 6 Mths at Earliest - AASTOCKS.com
How hedge fund analytics apply to TransCode Therapeutics Inc. stockJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com
CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs - South China Morning Post
TransCode Therapeutics Acquires Polynoma, Secures $25 Million Investment to Advance Oncology Pipeline - citybuzz
TransCode Therapeutics, Inc. (RNAZ) Stock :Soars as $25M Investment and Polynoma Acquisition Ignite Growth Prospects - parameter.io
TransCode Therapeutics To Acquire Polynoma; $25M Financing By a Subsidiary Of CK Life Sciences - citybiz
TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout - Benzinga
Transcode announces the acquisition of Polynoma and a $25 mln financing by subsidiary of CK Life Sciences - MarketScreener
TransCode Therapeutics stock soars after Polynoma acquisition By Investing.com - Investing.com Canada
TransCode Acquires Polynoma, Secures $25M Strategic Investment | RNAZ Stock News - Stock Titan
TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - Stocktwits
Chart based exit strategy for TransCode Therapeutics Inc.2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Strategies to average down on TransCode Therapeutics Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com
TransCode Therapeutics Amends Patent License Agreement - TipRanks
TransCode Therapeutics (NASDAQ:RNAZ) Trading Down 1.5% – What’s Next? - Defense World
Will TransCode Therapeutics Inc. stock go up soonMarket Activity Report & Growth Oriented Trade Recommendations - newser.com
Is TransCode Therapeutics Inc. stock bottoming outJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - newser.com
TransCode Therapeutics Passes Key Proposals at Annual Meeting - MSN
Developing predictive dashboards with TransCode Therapeutics Inc. dataMarket Sentiment Review & Safe Capital Allocation Plans - newser.com
TransCode Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Our Picks = Your Future Gains - earlytimes.in
What analysts say about TransCode Therapeutics Inc stockShort-Term Trading Alerts & Build a Smarter Portfolio Right Now - earlytimes.in
A activity2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
What to expect from CPSH in the next 30 daysWatch List & High Accuracy Swing Entry Alerts - newser.com
Is Mineralys Therapeutics Inc. stock poised for growthJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
NGVT stock trend outlook and recovery pathMarket Movement Recap & Safe Entry Momentum Tips - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):